Factors | Univariate | Multivariate | |||
---|---|---|---|---|---|
P value | HR | 95%CI | P value | ||
Gender(M/F) | 1.000 | Â | Â | Â | |
Age(≤60/>60y) | 0.359 |  |  |  | |
Tumor type (naive/recurrent) | 0.410 | Â | Â | Â | |
Etiology (Hepatitis/others) | 0.691 | Â | Â | Â | |
Type (Naïve/recurrent) | 0.299 |  |  |  | |
Surgery history of liver (Y/N) | 1.000 | Â | Â | Â | |
Liver cirrhosis (Y/N) | 0.113 | Â | Â | Â | |
ECOG performance status (0/1) | 0.765 | Â | Â | Â | |
Child-Pugh (A/B) | 0.104 | Â | Â | Â | |
BCLC stage of primary HCC (A/B) | 0.453 | Â | Â | Â | |
AFP (≥400/< 400 μg/L) | 0.861 |  |  |  | |
PLT (≥100/< 100 × 109/L) | 1.000 |  |  |  | |
PT (≤14/> 14 s) | 1.000 |  |  |  | |
ALB (≤35/> 35 g/L) | 1.000 |  |  |  | |
ALT (≤40/> 40 IU/L) | 0.164 |  |  |  | |
TB (≤17.1/> 17.1 mol/L) | 1.000 |  |  |  | |
Tumor number (single/multiple) | 1.000 | Â | Â | Â | |
Location (Paracaval portion/ Caudate process/ Spiegel’s lobe) | 0.727 |  |  |  | |
Tumor size (≤2 cm /> 2 cm) | 0.691 |  |  |  | |
Puncture approach (LA/ RA/ combination approach) | 0.724 | Â | Â | Â | |
Treatment strategy | RFA/ EA/ RFA-EA | 0.832 | Â | Â | Â |
EA/RFA or RFA-EA | 0.674 | Â | Â | Â | |
RFA or EA/RFA-EA | 1.000 | Â | Â | Â | |
AM (≥ 5 mm / < 5 mm) | 0.443 |  |  |  |